In 60 min. In this video we will revisit Aviptadil
Post# of 653
(Total Views: 270)
Posted On: 11/04/2020 5:01:14 PM
In 60 min. In this video we will revisit Aviptadil, also known as RLF-100, a synthetic Vasoactive Intestinal Peptide that is current undergoing clinical trials to treat COVID-19.
New data came out on Trial Site on 21 patients who received this therapy under the Emergency Use Authorization because they were so critically ill.
Interestingly, they had a 9x lower mortality than their control group. We do not have all the data published to compare these two groups, but nonetheless a very interesting finding!
We will discuss how this therapy works, the published data, and the ongoing clinical trials. Check out the video for all the details!
https://www.youtube.com/watch?v=H7MTo49kSP0
New data came out on Trial Site on 21 patients who received this therapy under the Emergency Use Authorization because they were so critically ill.
Interestingly, they had a 9x lower mortality than their control group. We do not have all the data published to compare these two groups, but nonetheless a very interesting finding!
We will discuss how this therapy works, the published data, and the ongoing clinical trials. Check out the video for all the details!
https://www.youtube.com/watch?v=H7MTo49kSP0
(1)
(1)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
Scroll down for more posts ▼